insights_auto
Why is CSBR down 4,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,40 US$
arrow_downward
-4,21%(-0,19) 1D
19 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,47 US$
High
4,47 US$
Low
4,40 US$
Mkt. cap
61,24 მლნ.
Avg. vol.
6,90 ათ.
Volume
0,00
52-wk high
8,31 US$
52-wk low
4,40 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,47 US$
High
4,47 US$
Low
4,40 US$
Mkt. cap
61,24 მლნ.
Avg. vol.
6,90 ათ.
Volume
0,00
52-wk high
8,31 US$
52-wk low
4,40 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
MarketForces Africa
·
25 წუთის წინ
S&P 500, Nasdaq, Dow Jones Dip Amidst Anthropic IPO Debut
Trefis
·
57 წუთის წინ
17 S&P 500 Stocks Hit 52-Week Lows On Thursday
Trefis
·
1 საათის წინ
S&P 500 Movers | Winners: PANW, OKTA, P | Losers: WSM, TWLO, AMD
Investing.com
·
45 წუთის წინ
S&P 500 Breaks Support as Global Risk Sentiment Begins to Crack
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com